Updated:
Acidophil
Acidophil is a single family office with offices in Pasadena, Boston, Amsterdam, Lutherville, and Basel.
Acidophil
Acidophil lists offices across Pasadena, Boston, Amsterdam, Lutherville, and Basel — an unusual footprint that suggests a European-North American operational reach. The firm's structure as a single family office is inferred from its classification, but no founding year, wealth origin, or named principals have been disclosed in public sources. This opacity limits the ability to trace the family's commercial roots. The firm's investment strategy and deployment activity are not specified in public records. It is unknown which asset classes, stages, or geographies Acidophil targets. No portfolio companies, deals, or co-investors have been identified. The geographic breadth of office locations may indicate a diversified global posture, but without confirmed holdings or mandates, this remains speculation. Team size, additional vehicles like philanthropic foundations, and recent operational activity are not publicly available. The five-office structure is the sole observable fact. No dated events from the last 24 months have been reported. Acidophil's most defining structural feature is its geographic dispersion — a single family office operating from five distinct cities across North America and Europe. This is unusual for a single-family office, which typically centers around one location. Without further disclosure, the rationale for this footprint — whether logistical, tax-driven, or investment-motivated — remains unclear.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Pasadena
Corporate office
Pasadena, CA, United States
Additional offices
Boston, MA, United States · Amsterdam, Netherlands · Lutherville, MD, United States · Basel, Switzerland
Frequently asked questions
Who runs investment decisions at Acidophil?
No named principals or investment decision-makers have been identified for Acidophil in public records. The firm's leadership structure is not disclosed.
Is Acidophil structured as a single family office or does it operate more like a multi-family office?
Available public information classifies Acidophil as a single family office. However, its five-office footprint across North America and Europe is atypical for a single-family office, which usually has one primary location.
What investment stages does Acidophil typically target?
Acidophil's investment-stage preferences are not publicly available. No deal activity, fund commitments, or direct investments have been cited in public sources.
Which sectors does Acidophil invest in?
Acidophil's sector focus has not been disclosed. No portfolio holdings or sector tags have been reported.
How is Acidophil related to any parent or related vehicle?
There is no public record of Acidophil being connected to any parent company, related family office, or spinout. Its corporate structure remains opaque.
Where does the underlying wealth come from?
The origin of wealth managed by Acidophil has not been publicly disclosed. No family name or commercial enterprise is associated with the firm in public records.
Does Acidophil participate in fund commitments or only direct deals?
Acidophil's approach to investing — whether through fund commitments, direct deals, or co-investments — is not specified in public sources. No transaction history is on record.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: